Venous Thromboembolism
The Ottawa Hospital Research Institute is involved in research on venous thromboembolism, with attention to conditions that affect venous circulation and clot formation. Its funded work includes clinical investigation in patients with prior thrombotic events.
- Venous thromboembolism
- Recurrent thrombotic events
- Antithrombotic prevention
Research activity in this area also extends to strategies aimed at reducing the return of clinically significant clotting episodes.
Deep Vein Thrombosis
The sponsor supports clinical research focused on deep vein thrombosis, addressing clot-related disease in the deep venous system. This includes interest in patients at risk of recurrent venous obstruction and related complications.
- Deep vein thrombosis
- Proximal venous clotting
- Secondary prevention
Its research landscape reflects concern with preventing further thrombotic events after an initial diagnosis.
Pulmonary Embolism
Clinical interest also includes pulmonary embolism, particularly events involving clinically significant obstruction in the pulmonary arteries. The funded trial activity links this area to prevention of recurrent embolic disease.
- Pulmonary embolism
- Segmental pulmonary embolism
- Symptomatic recurrence
This focus connects pulmonary vascular disease with broader management of venous clot recurrence.
Lipid-Modifying Therapy in Thrombotic Disease
The institute’s trial portfolio includes interest in statin therapy as a potential approach within thrombotic disease prevention, especially in patients with a history of venous thromboembolism. This reflects exploration of cardiovascular and hematologic overlap in clot prevention.
- Statin therapy
- Rosuvastatin
- Clot recurrence prevention
Research in this domain connects vascular medicine with preventive treatment strategies for patients at risk of further venous events.
